177,938 research outputs found
General -- January-June,1962 -- Correspondence, OPV Miscellaneous -- letter, 1962-06-15
No full textLetter from Pogge, R. C. to Sabin, Albert B. dated 1962-06-15.Sabin Collection Fair Use Policy</a
sj-R-6-hpq-10.1177_13591053211064986 – for Examining commonsense epidemiology: The case of asthma
No full textsj-R-6-hpq-10.1177_13591053211064986 for Examining commonsense epidemiology: The case of asthma by Gabrielle Pogge, Erika A Waters, Gregory D Webster, David Fedele, Sreekala Prabhakaran and James A Shepperd in Journal of Health Psychology</p
Morality and World Hunger
No full textBittner R. Morality and World Hunger. In: Pogge TW, ed. Global Justice. Metaphilosophy series in Philosophy. Oxford: Blackwell; 2001: 24-31
The optical counterpart of the radio source close to the Seyfert 2 nucleus of NGC 5953 = ARP 91 B
No full textSpectroscopic and morphological observations of the nuclear region of the Seyfert 2 galaxy NGC 5953 = Arp 91 B are presented. It is shown that an extended emitting region, with features typical of a supergiant H II region, is located to the west of the nucleus within a radio structure which is emitting as a nonthermal source with spectral index α = 0.6 in the 1.4-5.0 GHz range. The nonthermal radio emission is tentatively interpreted as the result of frequent supernova blasts and the consistency of this interpretation with the optical data is discussed. Another extended emitting region, located close to the nucleus to its east, in a position symmetrically opposite to the western region, is revealed by the present spectra
The Health Impact Fund: More justice and efficiency in global health
No full textSome 18 million people die annually from poverty-related causes. Many more are suffering grievously from treatable medical conditions. These burdens can be substantially reduced by supplementing the rules governing pharmaceutical innovation. Established by the World Trade Organization's TRIPS Agreement, these rules cause advanced medicines to be priced beyond the reach of the poor and steer medical research away from diseases concentrated among them. We should complement these rules with the Health Impact Fund. Financed by many governments, the HIF would offer any new pharmaceutical product the opportunity to participate, during its first ten years, in the HIF's annual reward pools, receiving a share equal to its share of the assessed global health impact of all HIF-registered products. In exchange, the innovator would have to agree to make this product available worldwide at the lowest feasible cost of manufacture. Fully consistent with TRIPS, the HIF achieves three key advances. It directs some pharmaceutical innovation toward the most serious diseases, including those concentrated among the poor. It makes all HIF-registered medicines cheaply available to all. And it incentivizes innovators to promote the optimal use of their HIF-registered medicines. Magnifying one another's effects, these advances would engender large global health gains.aid
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
"Closing the R&D Gap, Evaluating the Sources of R&D Spending"
No full textBoth spending and tax policies have been implemented in the United States with the goal of stimulating private sector research and development (R&D). Karier questions whether current R&D policy, especially the research and experimentation tax credit, can contribute to closing the gap between nondefense expenditures on R&D in the United States and such expenditures in other countries, such as Japan and Germany. He also explores possible changes to our current R&D policy to make it more effective.
Stronger Reasons
No full textBittner R. Stronger Reasons. In: Meyer LH, Paulson SL, Pogge TW, eds. Rights, Culture and the Law. Themes from the Legal and Political Philosophy of Joseph Raz. Oxford: Oxford University Press; 2003: 17-23
Going Beyond Counting First Authors in Author Co-citation Analysis
No full textThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Combating Antibiotic Resistance Through the Health Impact Fund
No full textThe Health Impact Fund (Hollis & Pogge 2008) is an innovative financing mechanism for global drug discovery and dissemination, separating the reward for successful R&D from the market price of the drug, also known as de-linkage. Aaron Kesselheim and Kevin Outterson have recently proposed a mechanism to reimburse companies for antibiotics according to their social value, but conditioned on achieving conservation goals to limit resistance (Kesselheim & Outterson 2010, 2011). This paper will explore whether this antibiotic resistance conservation proposal can be adapted to the framework of the Health Impact Fund. If these proposals can be meshed, then antibiotics might be an interesting therapeutic class for a test of the Health Impact Fund
- …
